Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6Sarcoma 4Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 17Fallopian Tube Neoplasms 6Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Sarcoma 2Recurrence 2Pancreatic Neoplasms 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Uterine Diseases 1Uterine Cervical Diseases 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Recurrent Uterine Corpus Sarcoma 1Prostatic Neoplasms 1Hypertension 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 4Paclitaxel 3Bevacizumab 3fludarabine 2Nivolumab 2Drug Therapy 2Cyclophosphamide 2Azacitidine 2vocimagene amiretrorepvec 1ulixertinib 1spartalizumab 1sapanisertib 1sacituzumab govitecan 1ruxolitinib 1rucaparib 1ridaforolimus 1regorafenib 1pazopanib 1motexafin gadolinium 1lenvatinib 1epacadostat 1cobimetinib 1cediranib 1cc-486 1carboxyamido-triazole 1aflibercept 1abiraterone 1Uncertainty 1Sirolimus 1Quality of Life 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × pazopanib × Gynecologic × Clear all
NCT01392352 2020-02-13

HYPAZ

Cambridge University Hospitals NHS Foundation Trust

Phase 2 Terminated
31 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡